Cargando…

Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study

Nail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyriakou, Aikaterini, Patsatsi, Aikaterini, Vyzantiadis, Timoleon-Achilleas, Sotiriadis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295582/
https://www.ncbi.nlm.nih.gov/pubmed/25614889
http://dx.doi.org/10.1155/2014/508178
_version_ 1782352869514543104
author Kyriakou, Aikaterini
Patsatsi, Aikaterini
Vyzantiadis, Timoleon-Achilleas
Sotiriadis, Dimitrios
author_facet Kyriakou, Aikaterini
Patsatsi, Aikaterini
Vyzantiadis, Timoleon-Achilleas
Sotiriadis, Dimitrios
author_sort Kyriakou, Aikaterini
collection PubMed
description Nail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23 p40, and IL-17 in psoriatic patients with and without nail involvement. 52 consecutively selected patients with chronic plaque psoriasis were included in this cross-sectional study. Patients were studied and analyzed after they had been divided into 2 groups regarding the presence (n = 24) or not (n = 28) of nail psoriasis. The mean serum levels of TNF-α were significantly higher in the group of psoriatic patients with nail lesions compared to those without (t-test; 5.40 ± 1.17 versus 3.80 ± 1.63, P = 0.026). However, the median serum levels of both IL-12/23 p40 (Mann-Whitney; 92.52 (34.35–126.87) versus 150.68 (35.18–185.86), P = 0.297) and IL-17 (Mann-Whitney; 28.49 (0.00–28.49) versus 8.59 (0.00–8.59), P = 0.714) did not significantly differ between the 2 groups. These results confirm the important role of TNF-α in the pathogenesis of nail psoriasis and may suggest that anti-TNF agents could be more beneficial in psoriatic nail disease than agents targeting IL-12/23 p40 or IL-17 and its receptors.
format Online
Article
Text
id pubmed-4295582
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-42955822015-01-22 Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study Kyriakou, Aikaterini Patsatsi, Aikaterini Vyzantiadis, Timoleon-Achilleas Sotiriadis, Dimitrios ScientificWorldJournal Research Article Nail involvement has started playing a major role in the overall assessment and management of psoriatic disease. Biologics indicated for moderate to severe chronic plaque psoriasis are shown to be beneficial in nail disease. This study aimed to assess and compare the serum levels of TNF-α, IL-12/23 p40, and IL-17 in psoriatic patients with and without nail involvement. 52 consecutively selected patients with chronic plaque psoriasis were included in this cross-sectional study. Patients were studied and analyzed after they had been divided into 2 groups regarding the presence (n = 24) or not (n = 28) of nail psoriasis. The mean serum levels of TNF-α were significantly higher in the group of psoriatic patients with nail lesions compared to those without (t-test; 5.40 ± 1.17 versus 3.80 ± 1.63, P = 0.026). However, the median serum levels of both IL-12/23 p40 (Mann-Whitney; 92.52 (34.35–126.87) versus 150.68 (35.18–185.86), P = 0.297) and IL-17 (Mann-Whitney; 28.49 (0.00–28.49) versus 8.59 (0.00–8.59), P = 0.714) did not significantly differ between the 2 groups. These results confirm the important role of TNF-α in the pathogenesis of nail psoriasis and may suggest that anti-TNF agents could be more beneficial in psoriatic nail disease than agents targeting IL-12/23 p40 or IL-17 and its receptors. Hindawi Publishing Corporation 2014 2014-12-31 /pmc/articles/PMC4295582/ /pubmed/25614889 http://dx.doi.org/10.1155/2014/508178 Text en Copyright © 2014 Aikaterini Kyriakou et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kyriakou, Aikaterini
Patsatsi, Aikaterini
Vyzantiadis, Timoleon-Achilleas
Sotiriadis, Dimitrios
Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_full Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_fullStr Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_full_unstemmed Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_short Serum Levels of TNF-α, IL-12/23 p40, and IL-17 in Psoriatic Patients with and without Nail Psoriasis: A Cross-Sectional Study
title_sort serum levels of tnf-α, il-12/23 p40, and il-17 in psoriatic patients with and without nail psoriasis: a cross-sectional study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295582/
https://www.ncbi.nlm.nih.gov/pubmed/25614889
http://dx.doi.org/10.1155/2014/508178
work_keys_str_mv AT kyriakouaikaterini serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT patsatsiaikaterini serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT vyzantiadistimoleonachilleas serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy
AT sotiriadisdimitrios serumlevelsoftnfail1223p40andil17inpsoriaticpatientswithandwithoutnailpsoriasisacrosssectionalstudy